Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant
Autores:Lena Miloradovic, Simon Greens, Tina Luke, Qiyuan Chen, Nicole A. Mifsud, Jonathan Cebon, Weisan Chen, Heather Jackson, Kelly-Anne Masterman, Lloyd J. Old, Mark Rizkalla, Wendie Hopkins, Tsin Yee Tai, He-Cheng Zhu, Nektaria Dimopoulos, Heather Goldie, Eugene Maraskovsky, James McCluskey, Phillip Parerute, Ian D. Davis